Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3186studies shown
Showing 2,526-2,550 of 3,186
CompletedNCT04182113

rTMS as a Probe of Episodic Memory Neurocircuitry in Schizophrenia

This study exists to see whether brain scans or other body measurements is workable and worth testing more broadly. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
Not Yet RecruitingNCT05948111

Assessment of Schizophrenia Patients' Clinical Study Experiences

This study exists to see whether symptom tracking and monitoring can make care clearer and more responsive. Researchers are trying to understand whether symptom tracking and monitoring can give earlier or clearer feedback during care.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Power Life Sciences Inc.
Condition
Schizophrenia
CompletedNCT01291511

Relapse Prevention Study in Patients With Schizophrenia

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
India, Ukraine, United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
CompletedNCT04221269

Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Butler Hospital
Condition
Schizophrenia
CompletedNCT01521026

Cognitive Training for Patients With Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
CompletedNCT03671525

Cognitive Effects of Nimodipine in Patients With Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Schizophrenia
CompletedNCT03962348

Clinical Interviews With Detainees With Early Psychosis

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 30 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
CompletedNCT04268303

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia

This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
BioXcel Therapeutics Inc
Condition
Schizophrenia
CompletedNCT03617783

Prebiotic Treatment in People With Schizophrenia - Pilot Study

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
TerminatedNCT04421456

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Poland, Serbia, Spain, United States
Sponsor
Jazz Pharmaceuticals
Condition
Schizophrenia
CompletedNCT02505477

Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
CompletedNCT03826563

Melatonin Effects on Sleep and Circadian Rhythm in Youth and Young Adults With At-risk Symptoms

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 11 Years to 30 Years
Countries
United States
Sponsor
Children's Hospital of Philadelphia
Condition
Schizophrenia
CompletedNCT03397134

Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of Schizophrenia

This study exists to compare options and see whether the medication MIN-101 offers something meaningfully different. Researchers are trying to understand how people respond to the medication MIN-101 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Bulgaria, Poland, Ukraine, United States
Sponsor
Minerva Neurosciences
Condition
Schizophrenia
CompletedNCT04922593

Relative Bioavailability of LY03010 Compared to Listed Drug

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
CompletedNCT04689867

Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Michigan
Condition
Schizophrenia
CompletedNCT02131129

rTMS in First Episode Psychosis

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
CompletedNCT03745820

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Germany, Japan, Spain, United Kingdom, United States
Sponsor
Biogen
Condition
Schizophrenia
CompletedNCT03270098

Improving Cognition Via Exercise in Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Schizophrenia
CompletedNCT04010747

Pilot Study of Motivational Interviewing for Loved Ones

This study exists to see whether the medication Motivational is workable and worth testing more broadly. Researchers are trying to understand what helps the medication Motivational stay useful, realistic, and easier to follow over time.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Boston Medical Center
Condition
Schizophrenia
CompletedNCT00635700

Ziprasidone in the Psychosis Prodrome

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 16 Years to 40 Years
Countries
Canada, United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT05601050

Linguistic Predictors of Outcomes in Psychosis

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 40 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
United States | Clinical Trials | HopeStage Research